NCT04137172

Brief Summary

entral hernias are a major cause of functional impairment, abdominal pain, and bowel obstruction. The overall incidence of primary ventral hernia is estimated to be between 4 and 5 % in the literature, and ventral incisional hernia rates vary from 35 to 60 % within 5 years after laparotomy . After laparoscopy, this rate is estimated to decline from 0.5 to 15 % even after two decades, LVHR or open repair (OVHR) is still a matter of debate because of concerns about seroma formation, recurrence rate, and the intraperitoneal mesh position. . The laparoscopic technique for repairing ventral and incisional hernias is now well established. However, several issues related to LVHR, such as the high recurrence rate of hernias with large fascial defects and in extremely obese patients, are yet to be resolved. Additional problems include seroma formation. To solve these problems, laparoscopic fascial defect closure with IPOM reinforcement (IPOM-Plus) has been introduced in the past decade, and a few studies have reported satisfactory outcomes. Although detailed techniques for fascial defect closure and handling of the mesh have been published, standardized techniques are yet to be established.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
177

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2016

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 3, 2016

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 30, 2019

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 29, 2019

Completed
15 days until next milestone

First Submitted

Initial submission to the registry

October 14, 2019

Completed
9 days until next milestone

First Posted

Study publicly available on registry

October 23, 2019

Completed
Last Updated

November 5, 2019

Status Verified

October 1, 2019

Enrollment Period

2.9 years

First QC Date

October 14, 2019

Last Update Submit

October 31, 2019

Conditions

Keywords

ventral hernia - LVHR-transfacial repair

Outcome Measures

Primary Outcomes (1)

  • post operative complications

    Total number of days spent in the hospital. This will be calculated by adding the hospital length of stay for initial surgery, length of stay for any additional readmission resulting from the surgery, and emergency room visits resulting from the surgery

    6 months

Secondary Outcomes (3)

  • adequacy of different techniques

    6 months to one year

  • Surgical Site Occurrence (SSO)

    6 months to one year

  • Hernia Reoccurence

    6 months to one year

Study Arms (3)

group1

EXPERIMENTAL

underwent laparoscopic IPOM hernioplasty without repair

Procedure: laparoscopic (IPOM) hernioplasty without repair

group2

EXPERIMENTAL

underwent laparoscopic IIPOM hernioplasty with intracorporeal repair using proline 0 versus stratifix PDS

Procedure: aparoscopic IIPOM hernioplasty with intracorporeal repair using proline 0 versus stratifix PDS

group3

EXPERIMENTAL

underwent laparoscopic IPOM hernioplasty with transfacial closure using PDS LOOP 0

Procedure: laparoscopic IPOM hernioplasty with transfacial closure using PDS LOOP 0

Interventions

Under general anesthesia, supine position, lateral visiport 12mm was inserted at the left anterior axillary line . Other two 5mm ports were inserted under vision. A 30-degree optics were used. Adhesiolysis was done . The contents of hernia were reduced . The borders of the defect were illuminated and outlined. The abdominal wall was marked from outside for measurement of defect size and for corners fixation of mesh with 5cm away from defect edge. Defect with axis from 9 to 12 cm is considered big defect. Group I: Proline (1) sutures were applied at the corners of the mesh introduced into the peritoneal cavity. Endoclose passed at the marked site from abdominal wall, sutures hanged and tied subcutaneously, completion of mesh fixation using secure strap .

group1

Group II: Using PDS 0, a stratifix suture (STRATAFIX™ Symmetric PDS™ Plus Knotless Tissue Control Device) versus proline 1 , used to repair and plicate the defect then mesh fixation

group2

The PDS loop sutures were prepared by cutting the needles, keeping two detached ends and one blind end. A small curved supraumbilical incision was done. The endoclose passed through upper border of incision penetrating the abdominal wall above the defect, hanging the blind end of the PDS Loop to outside. It passed through the lower border of the wound crossing the defect. It hanged one detached end of the PDS Loop suture to outside, passed again through lower border of incision to catch the other detached end. The two ends were hanged not tied to avoid incision closure. The process is repeated by passing 1-2 cm lateral or medial to the previous sutures, then blind ends were divided. Lastly, all sutures are tied. Mesh was fixed as before.

group3

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patients over 18 years undergoing surgery for primary or incisional ventral hernia
  • defect whose major axis not exceeding 12cm.

You may not qualify if:

  • Patients undergoing revision
  • Emergency surgery.
  • Parastomal hernias were not included.
  • Patients not candidate for laparoscopy including cardiac and COPD patients

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Zagazig Unversity

Zagazig, Egypt

Location

MeSH Terms

Conditions

Hernia

Interventions

LaparoscopyHerniorrhaphyWound Healing

Condition Hierarchy (Ancestors)

Pathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

EndoscopyDiagnostic Techniques, SurgicalDiagnostic Techniques and ProceduresDiagnosisMinimally Invasive Surgical ProceduresSurgical Procedures, OperativePlastic Surgery ProceduresRegenerationBiological Phenomena

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
assistant profeosser

Study Record Dates

First Submitted

October 14, 2019

First Posted

October 23, 2019

Study Start

October 3, 2016

Primary Completion

August 30, 2019

Study Completion

September 29, 2019

Last Updated

November 5, 2019

Record last verified: 2019-10

Locations